From the Tactical and EnRoute Care Research Department, US Army Institute of Surgical Research, JBSA Fort Sam Houston, TX.
J Trauma Acute Care Surg. 2020 Aug;89(2S Suppl 2):S93-S99. doi: 10.1097/TA.0000000000002604.
Peripheral vasoconstriction is the most critical compensating mechanism following hemorrhage to maintain blood pressure. On the battlefield, ketamine rather than opioids is recommended for pain management in case of hemorrhage, but effects of analgesics on compensatory vasoconstriction are not defined. We hypothesized that fentanyl impairs but ketamine preserves the peripheral vasoconstriction and blood pressure compensation following hemorrhage.
Sprague-Dawley rats (11-13 weeks) were randomly assigned to control (saline vehicle), fentanyl, or ketamine-treated groups with or without hemorrhage (n = 8 or 9 for each group). Rats were anesthetized with Inactin (i.p. 10 mg/100 g), and the spinotrapezius muscles were prepared for microcirculatory observation. Arteriolar arcades were observed with a Nikon microscope, and vessel images and arteriolar diameters were recorded by using Nikon NIS Elements Imaging Software (Nikon Instruments Inc. NY). After baseline perimeters were recorded, the arterioles were topically challenged with saline, fentanyl, or ketamine at concentrations relevant to intravenous analgesic doses to determine direct vasoactive effects. After arteriolar diameters returned to baseline, 30% of total blood volume was removed in 25 minutes. Ten minutes after hemorrhage, rats were intravenously injected with an analgesic dose of fentanyl (0.6 μg/100 g), ketamine (0.3 mg/100 g), or a comparable volume of saline. For each drug or vehicle administration, the total volume injected was 0.1 mL/100 g. Blood pressure, heart rate, and arteriolar responses were monitored for 40 minutes.
Topical fentanyl-induced vasodilation (17 ± 2%), but ketamine caused vasoconstriction (-15 ± 4%, p < 0.01). Following hemorrhage, intravenous ketamine did not affect blood pressure or respiratory rate, while fentanyl induced a slight and transient (<5 minutes, p = 0.03 vs. saline group) decrease in blood pressure, with a profound and prolonged suppression in respiratory rate (>10 minutes, with a peak inhibition of 57 ± 8% of baseline, p < 0.01). The compensatory vasoconstriction observed after hemorrhage was not affected by ketamine treatment. However, after fentanyl injection, although changes in blood pressure were transiently present, arteriolar constriction to hemorrhage was absent and replaced with a sustained vasodilation (78 ± 25% to 36 ± 22% of baseline during the 40 minutes after injection, p < 0.01).
Ketamine affects neither systemic nor microcirculatory compensatory responses to hemorrhage, providing preclinical evidence that ketamine may help attenuate adverse physiological consequences associated with opioids following traumatic hemorrhage. Microcirculatory responses are more sensitive than systemic response for evaluation of hemodynamic stability during procedures associated with pain management.
外周血管收缩是出血后维持血压的最关键的代偿机制。在战场上,建议在出血情况下使用氯胺酮而不是阿片类药物来进行疼痛管理,但镇痛药对代偿性血管收缩的影响尚不清楚。我们假设芬太尼会损害,但氯胺酮会保留出血后外周血管收缩和血压代偿。
将 Sprague-Dawley 大鼠(11-13 周)随机分为对照组(生理盐水载体)、芬太尼组或氯胺酮组,无论是否发生出血(每组 8 或 9 只)。大鼠用 Inactin(腹腔内 10mg/100g)麻醉,并准备好斜方肌进行微循环观察。用 Nikon 显微镜观察动脉弓,并用 Nikon NIS Elements 成像软件(Nikon Instruments Inc. NY)记录血管图像和动脉直径。记录基线周长后,用生理盐水、芬太尼或氯胺酮以与静脉镇痛剂量相关的浓度局部刺激动脉弓,以确定直接血管活性作用。动脉直径恢复到基线后,在 25 分钟内取出总血容量的 30%。出血后 10 分钟,大鼠静脉注射芬太尼(0.6μg/100g)、氯胺酮(0.3mg/100g)或相当体积的生理盐水的镇痛剂量。每种药物或载体的注射总量为 0.1mL/100g。监测血压、心率和动脉反应 40 分钟。
局部芬太尼诱导血管扩张(17±2%),但氯胺酮引起血管收缩(-15±4%,p<0.01)。出血后,静脉注射氯胺酮不影响血压或呼吸频率,而芬太尼仅引起短暂(<5 分钟,p=0.03 与生理盐水组相比)的血压下降,同时显著且持久地抑制呼吸频率(>10 分钟,最大抑制达基线的 57±8%,p<0.01)。出血后观察到的代偿性血管收缩不受氯胺酮治疗的影响。然而,芬太尼注射后,尽管血压变化短暂存在,但动脉对出血的收缩反应消失,取而代之的是持续的血管扩张(40 分钟内从基础值的 78±25%到 36±22%,p<0.01)。
氯胺酮既不影响全身也不影响出血后的微循环代偿反应,为氯胺酮可能有助于减轻创伤性出血后与阿片类药物相关的不良生理后果提供了临床前证据。在与疼痛管理相关的过程中,微循环反应比全身反应更敏感,可用于评估血流动力学稳定性。